Sign In

Login

Password

Forgot Password ? Sign Up

Онколитический вирус (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Онколитический вирус" in Russian language version.

refsWebsite
Global rank Russian rank
12nih.gov
4th place
6th place
7doi.org
2nd place
3rd place
4web.archive.org
1st place
1st place
2semanticscholar.org
11th place
286th place
1ibiotherapy.com
low place
low place
1sciencebasedmedicine.org
5,063rd place
3,223rd place
1zva.gov.lv
low place
low place
1archive.org
6th place
9th place
1onclive.com
low place
low place

archive.org

doi.org

  • Ferguson MS, Lemoine NR, Wang Y (2012). "Systemic delivery of oncolytic viruses: hopes and hurdles". Advances in Virology. 2012: 1—14. doi:10.1155/2012/805629. PMC 3287020. PMID 22400027.
  • Melcher A, Parato K, Rooney CM, Bell JC (June 2011). "Thunder and lightning: immunotherapy and oncolytic viruses collide". Molecular Therapy. 19 (6): 1008—16. doi:10.1038/mt.2011.65. PMC 3129809. PMID 21505424.
  • Lichty BD, Breitbach CJ, Stojdl DF, Bell JC (August 2014). "Going viral with cancer immunotherapy". Nature Reviews. Cancer. 14 (8): 559—67. doi:10.1038/nrc3770. PMID 24990523. S2CID 15182671.
  • Alemany R (March 2013). "Viruses in cancer treatment". Clinical & Translational Oncology. 15 (3): 182—8. doi:10.1007/s12094-012-0951-7. PMID 23143950. S2CID 6123610.
  • Donnelly OG, Errington-Mais F, Prestwich R, Harrington K, Pandha H, Vile R, Melcher AA (July 2012). "Recent clinical experience with oncolytic viruses". Current Pharmaceutical Biotechnology. 13 (9): 1834—41. doi:10.2174/138920112800958904. PMID 21740364.
  • Rudin CM, Poirier JT, Senzer NN, Stephenson J, Loesch D, Burroughs KD, Reddy PS, Hann CL, Hallenbeck PL (February 2011). "Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features". Clinical Cancer Research. 17 (4): 888—95. doi:10.1158/1078-0432.CCR-10-1706. PMC 5317273. PMID 21304001.
  • Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, Daar AS, Singer PA (January 2008). "Chinese health biotech and the billion-patient market". Nature Biotechnology. 26 (1): 37—53. doi:10.1038/nbt0108-37. PMC 7096943. PMID 18183014.

ibiotherapy.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Ferguson MS, Lemoine NR, Wang Y (2012). "Systemic delivery of oncolytic viruses: hopes and hurdles". Advances in Virology. 2012: 1—14. doi:10.1155/2012/805629. PMC 3287020. PMID 22400027.
  • Melcher A, Parato K, Rooney CM, Bell JC (June 2011). "Thunder and lightning: immunotherapy and oncolytic viruses collide". Molecular Therapy. 19 (6): 1008—16. doi:10.1038/mt.2011.65. PMC 3129809. PMID 21505424.
  • Lichty BD, Breitbach CJ, Stojdl DF, Bell JC (August 2014). "Going viral with cancer immunotherapy". Nature Reviews. Cancer. 14 (8): 559—67. doi:10.1038/nrc3770. PMID 24990523. S2CID 15182671.
  • Alemany R (March 2013). "Viruses in cancer treatment". Clinical & Translational Oncology. 15 (3): 182—8. doi:10.1007/s12094-012-0951-7. PMID 23143950. S2CID 6123610.
  • Donnelly OG, Errington-Mais F, Prestwich R, Harrington K, Pandha H, Vile R, Melcher AA (July 2012). "Recent clinical experience with oncolytic viruses". Current Pharmaceutical Biotechnology. 13 (9): 1834—41. doi:10.2174/138920112800958904. PMID 21740364.
  • Roberts MS, Lorence RM, Groene WS, Bamat MK (August 2006). "Naturally oncolytic viruses". Current Opinion in Molecular Therapeutics. 8 (4): 314—21. PMID 16955694.
  • Rudin CM, Poirier JT, Senzer NN, Stephenson J, Loesch D, Burroughs KD, Reddy PS, Hann CL, Hallenbeck PL (February 2011). "Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features". Clinical Cancer Research. 17 (4): 888—95. doi:10.1158/1078-0432.CCR-10-1706. PMC 5317273. PMID 21304001.
  • Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, Daar AS, Singer PA (January 2008). "Chinese health biotech and the billion-patient market". Nature Biotechnology. 26 (1): 37—53. doi:10.1038/nbt0108-37. PMC 7096943. PMID 18183014.

ncbi.nlm.nih.gov

  • Ferguson MS, Lemoine NR, Wang Y (2012). "Systemic delivery of oncolytic viruses: hopes and hurdles". Advances in Virology. 2012: 1—14. doi:10.1155/2012/805629. PMC 3287020. PMID 22400027.
  • Melcher A, Parato K, Rooney CM, Bell JC (June 2011). "Thunder and lightning: immunotherapy and oncolytic viruses collide". Molecular Therapy. 19 (6): 1008—16. doi:10.1038/mt.2011.65. PMC 3129809. PMID 21505424.
  • Rudin CM, Poirier JT, Senzer NN, Stephenson J, Loesch D, Burroughs KD, Reddy PS, Hann CL, Hallenbeck PL (February 2011). "Phase I clinical study of Seneca Valley Virus (SVV-001), a replication-competent picornavirus, in advanced solid tumors with neuroendocrine features". Clinical Cancer Research. 17 (4): 888—95. doi:10.1158/1078-0432.CCR-10-1706. PMC 5317273. PMID 21304001.
  • Frew SE, Sammut SM, Shore AF, Ramjist JK, Al-Bader S, Rezaie R, Daar AS, Singer PA (January 2008). "Chinese health biotech and the billion-patient market". Nature Biotechnology. 26 (1): 37—53. doi:10.1038/nbt0108-37. PMC 7096943. PMID 18183014.

onclive.com

sciencebasedmedicine.org

semanticscholar.org

api.semanticscholar.org

web.archive.org

zva.gov.lv